HSBC Holdings
PGEN icon

HSBC Holdings’s Precigen PGEN Stock Holding History

HSBC Holdings’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-15,573
Closed -$22.3K – 3193
2025
Q1 		$22.3K Sell
15,573
-103
-0.7% -$162 ﹤0.01% 2963
2024
Q4 		$16.3K Buy
+15,676
New +$13.4K ﹤0.01% 3056
2024
Q3 		– Sell
-13,594
Closed -$20.5K – 3114
2024
Q2 		$20.5K Buy
13,594
+129
+1% +$187 ﹤0.01% 2873
2024
Q1 		$19.5K Buy
+13,465
New +$19.3K ﹤0.01% 2996
2020
Q3 		– Sell
-16,113
Closed -$80K – 2820
2020
Q2 		$80K Buy
+16,113
New +$54.8K ﹤0.01% 2544

Other funds holding PGEN

PCM
Patient Capital Management Baltimore, Maryland $2.74B AUM 43.59% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

HSBC Holdings's PGEN Position: Q2 2025 in Review

HSBC Holdings sold out of Precigen (PGEN) in Q2 2025, closing a stake of 15,573 shares — an estimated $22.3K sold.

HSBC Holdings first reported a position in PGEN in Q2 2020 and held it in 5 quarters. The position peaked at $80K in Q2 2020. 147 funds tracked by Wall St. Rank hold PGEN as of Q2 2025.

  • HSBC Holdings reported no remaining Precigen position as of Q2 2025 after selling out during the quarter.
  • HSBC Holdings sold 15,573 Precigen shares in Q2 2025, an estimated $22.3K.
  • HSBC Holdings first reported a position in Precigen in Q2 2020 and held it in 5 quarters.
  • HSBC Holdings's Precigen position peaked at $80K in Q2 2020.
  • 147 funds tracked by Wall St. Rank held Precigen as of Q2 2025.

Based on HSBC Holdings's 13F filing for Q2 2025, filed 13 Aug 2025.